Structure-Based Design of Potent Retinoid X Receptor α Agonists
Curt D. Haffner, James M. Lenhard, Aaron B. Miller et al. · Journal of Medicinal Chemistry · 2004
A series of tetrahydrobenzofuranyl and tetrahydrobenzothienyl propenoic acids that showed potent agonist activity against RXRalpha were synthesized via a structure-based design approach. Among the compounds studied, 46a,b showed not only very good potency against RXRalpha (K(i) = 6 nM) but was also found to be greater than 167-fold selective vs RARalpha (K(i) > 1000 nM). This compound profiled out as a full agonist in a cell-based transient transfection assay (EC(50) = 3 nM). The two antipodes were separated via chiral chromatography, and 46b was found to be 40-fold more potent than 46a. Interestingly, cocrystallization of 46a,b with the RXRalpha protein generated a liganded structure whereby the (S)-antipode was found in the binding pocket. Given orally in db/db mice or ZDF rats, 46a,b showed a significant glucose-lowering effect and an increase in liver mass. Triglycerides decreased significantly in db/db mice but increased in the ZDF rats. A dose-dependent decrease of nonesterified free fatty acids was seen in ZDF rats but not in db/db mice. These differences indicate a species specific effect of RXR agonists on lipid metabolism.
Cited by 48 works. doi:10.1021/jm030565g
Authors
- Curt D. Haffner
- James M. Lenhard
- Aaron B. Miller
- Darryl L. McDougald
- Kate A. Dwornik
- Olivia R. R. Ittoop
- H. Eric Xu
- Steve Blanchard
- Valerie G. Montana
- T.G. Consler
- Randy K. Bledsoe
- Andrea H. Ayscue
- Dallas K. Croom
References
- Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
- AMoRe: an automated package for molecular replacement
- Identification of a receptor for the morphogen retinoic acid
- Nuclear receptor that identifies a novel retinoic acid response pathway
- 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
- A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR
- 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα
- Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
- Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
- Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.